Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma

This article has been corrected: In Figure 2D, parts of the NC and miR-29a-3p panels are accidental duplicates. The corrected Figure 2, obtained using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Figure 2. Overexpression of miR-29a-3p inhibited cancer cell growth and migration in vitro and in vivo.

(A) QRT-PCR analysis of miR-29a-3p expression in normal human hepatic cell line (LO2) and HCC cells lines (SMMC-7721, Hep3B, HepG2, and Huh 7). (B) Proliferation ability test by CCK8 assay of HepG2 cells after transfection with miR-29a-3p mimics, negative control (NC) or no transfection (untreated). (C) Colony formation assay and statistical results in HepG2 cells after transfection with miR-29a-3p mimics, NC or untreated. (D) Wound healing assay of HepG2 cells after transfection with the miR-29a-3p mimics, NC or untreated. (E) Transwell migration assay of HepG2 cells after transfection with the miR-29a-3p mimics, NC or untreated. (F) Functional test of miR-29a-3p in vivo and statistical results. (^* P < 0.05, ^** P < 0.01, ^*** P < 0.001).

Original article: Oncotarget. 2017; 8:86592–86603. 86592-86603. https://doi.org/10.18632/oncotarget.21246